The share of cheap drugs in the Russian pharmaceutical market is steadily declining, while in the last three years their overall range in the market has declined two-fold, reports The Pharma Letter’s local correspondent.
According to Russian pharma analytics agency DSM Group, in 2023, the overall range of drugs in Russian pharmacies fell by 11% compared to the previous year - from 21.600 to 19.400 trade items, and the decline is ongoing.
The largest drop over the year was observed in case of the cheapest drugs with the cost of $1.50-$2.00. Their number decreased by 24% year-on-year - from 5.700 trading positions in 2022 to 4.600 units.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze